Q-CTRL, the global leader in quantum infrastructure software, today announced the successful expansion of its Series B Funding Round to USD$113M (AUD$166M), with USD $59M of new capital.
MAJOR DISEASES IDENTIFIED THAT ARE LINKED TO EPITHELIAL BARRIER DEFECT AND MICROBIOME CHANGES Epithelial barrier theory-related diseases, microbial dysbiosis and inflammation • To explain the growing prevalence of allergic, autoimmune and neuropsychiatric diseases, the epithelial barrier theory is a central focus of worldwide opinion leaders.
. The Integrated Visual Augmentation System (IVAS) had been developed to provide soldiers with enhanced situational awareness and combat capabilities by integrating next-generation technologies into a single wearable device.
Consensus Gentium today announced the global availability of its SXSW 2023 award-winning app Consensus Gentium I on the Apple App Store. This interactive app invites users to experience the pressing realities of AI bias and surveillance through immersive storytelling, placing them at the heart of the AI debate.
The QInnovision Consortium, led by Vernewell Group, announces the launch of the Quantum Industry Day (QID) series, with the inaugural event, taking place on Friday, October 4, 2024, co-organized by QInnovision’s founding member, the Center for Quantum and Topological Systems (CQTS) at New York University Abu Dhabi (NYUAD).
GenieUs Genomics (GenieUs), in collaboration with trial sites at Duke University School of Medicine and the Lewis Katz School of Medicine at Temple University, today announces the completion of enrollment of 50 patients in the Phase 2 clinical trial, ROAR-DiGAP, focused on precision health and patient stratification in amyotrophic lateral sclerosis (ALS).
On October 4, 2024, in celebration of the United Nations-declared World Space Week, the Cosmic Girls™ Foundation is proud to launch a global competition designed to inspire young women to pursue careers in space and the fields of science, technology, engineering, and mathematics (STEM).
